Autoimmune Dysautonomia Evaluation

Ganglionic Acetylcholine Receptor (AChR) Autoantibody

February 2011

Antibody values greater than 1.0 nanomoles per liter are usually associated with profound dysautonomia and widespread dysautonomia. Values of 0.03 to 0.99 nanomoles per liter are often associated with more limited disorders. Cancer is detected in 30% of seropositive patients. These cancers can include adenocarcinomas, small cell lung carcinoma, thymoma or lymphoma.

< Previous Slide

Ganglionic AChR Autoantibody

Next Slide >

 

Jump to section:

• Introduction
• New Profile
• Autoimmune Dysautonomia
• Autoimmune Dysautonomia
• Autoimmune Dysautonomia^1,2
• Pandysautonomia
• Limited Dysautonomia³
• Objective Testing
• Thermoregulatory Sweat Testing
• Antibody Testing
• Ganglionic Acetylcholine Receptor (AChR) Autoantibody
• Ganglionic Acetylcholine Receptor (AChR) Autoantibody
• Autoimmune Dysautonomia Antibody Profile
• Autoimmune Dysautonomia Evaluation Testing Algorithm
• Clinical Utility of Autoimmune Dysautonomia Evaluation
• Clinical Utility of Autoimmune Dysautonomia Evaluation
• Summary
• References
• Questions?